IP Library › Granted Patent US 7,589,056
Granted Patent B2
US 7,589,056 · App. 10/472,439 · Granted Sep 15, 2009

Agent for the prevention and treatment of sexually transmitted diseases-I

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,589,056
App. No.
10/472,439
Filed
Aug 25, 2004
Granted
Sep 15, 2009
Kind
B2
Art Unit
1618
USPC
514/1
Abstract

Use of a polylysine, polyamidoamine or polypropylenimine dendrimer having naphthyl disulphonate terminal groups as a topically applied agent in prophylaxis or treatment of sexually transmitted diseases.

Claims (10)

1. A compound of the formula I:

wherein R represents a group of the formula IV:

wherein * indicates the point of attachment,

or a pharmaceutically acceptable salt thereof.

2. The compound according to claim 1 , wherein the pharmaceutically acceptable salt is selected from metallic salts, organic salts made from organic amines, quaternary amine salts, sulphonium salts, and phosphonium salts.

3. The compound of claim 1 , wherein the compound is SPL-7013.

4. A topical pharmaceutical composition comprising a compound according to claim 1 , in association with at least one pharmaceutically acceptable, topical carrier or diluent.

5. The compound according to claim 2 , wherein said metallic salt is selected from the group consisting of aluminum, calcium, lithium, magnesium, potassium, sodium, zinc salts.

6. The compound according to claim 2 , wherein said organic salt of organic amine is selected from the group consisting of N,N′-dibenzylethylenediamine, chloroprocaine, diethanolamine, ethylenediamine, dicyclohexylamine, meglumine (N-methylglucamine) and procaine.

7. The compound according to claim 2 , wherein said quatemary amine salt is choline.